BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$6.43B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
124
New
Increased
Reduced
Closed

Top Buys

1
+$134M
2
+$93M
3
+$83.3M
4
ADCT icon
ADC Therapeutics
ADCT
+$79M
5
ADAP
Adaptimmune Therapeutics
ADAP
+$29.9M

Top Sells

1
+$474M
2
+$101M
3
+$51.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$40.7M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$22.8M

Sector Composition

1 Healthcare 97.74%
2 Financials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$5.57M 0.02%
317,857
+142,857
77
$5.32M 0.02%
+1,522,792
78
$5.09M 0.02%
+946,701
79
$4.86M 0.02%
1,058,555
-719,860
80
$4.64M 0.02%
63,627
81
$4.03M 0.02%
95,000
+53,580
82
$4.01M 0.02%
133,333
83
$3.38M 0.01%
458,253
+388,782
84
$3.11M 0.01%
+60,000
85
$3.06M 0.01%
425,000
86
$3.05M 0.01%
+666,666
87
$3.03M 0.01%
119,335
+37,400
88
$3.01M 0.01%
121,534
89
$2.97M 0.01%
47,000
90
$2.84M 0.01%
244,055
-242,278
91
$2.7M 0.01%
128,538
92
$2.58M 0.01%
13,072
93
$2.57M 0.01%
27,000
94
$2.54M 0.01%
104,900
95
$2.46M 0.01%
124,400
-125,600
96
$2.43M 0.01%
40,570
97
$2.38M 0.01%
65,934
98
$2.36M 0.01%
150,000
99
$2.31M 0.01%
500,000
-560,714
100
$2.18M 0.01%
10,548
-5,313
1 2 3
4
5